291 related articles for article (PubMed ID: 21596592)
41. Enhanced activation of T lymphocytes by urease-deficient recombinant bacillus Calmette-Guérin producing heat shock protein 70-major membrane protein-II fusion protein.
Mukai T; Maeda Y; Tamura T; Matsuoka M; Tsukamoto Y; Makino M
J Immunol; 2010 Nov; 185(10):6234-43. PubMed ID: 20935209
[TBL] [Abstract][Full Text] [Related]
42. Trafficking of superinfecting Mycobacterium organisms into established granulomas occurs in mammals and is independent of the Erp and ESX-1 mycobacterial virulence loci.
Cosma CL; Humbert O; Sherman DR; Ramakrishnan L
J Infect Dis; 2008 Dec; 198(12):1851-5. PubMed ID: 18983252
[TBL] [Abstract][Full Text] [Related]
43.
Choi S; Choi HG; Shin KW; Back YW; Park HS; Lee JH; Kim HJ
J Immunol Res; 2018; 2018():3525302. PubMed ID: 29736404
[TBL] [Abstract][Full Text] [Related]
44. Intracerebral Mycobacterium bovis bacilli Calmette-Guerin infection-induced immune responses in the CNS.
Lee J; Ling C; Kosmalski MM; Hulseberg P; Schreiber HA; Sandor M; Fabry Z
J Neuroimmunol; 2009 Aug; 213(1-2):112-22. PubMed ID: 19535154
[TBL] [Abstract][Full Text] [Related]
45. Enhanced immune response in Mycobacterium bovis bacille calmette guerin (BCG)-infected IL-10-deficient mice.
Jacobs M; Fick L; Allie N; Brown N; Ryffel B
Clin Chem Lab Med; 2002 Sep; 40(9):893-902. PubMed ID: 12435106
[TBL] [Abstract][Full Text] [Related]
46. Lipocalin 2 regulates inflammation during pulmonary mycobacterial infections.
Guglani L; Gopal R; Rangel-Moreno J; Junecko BF; Lin Y; Berger T; Mak TW; Alcorn JF; Randall TD; Reinhart TA; Chan YR; Khader SA
PLoS One; 2012; 7(11):e50052. PubMed ID: 23185529
[TBL] [Abstract][Full Text] [Related]
47. An anti-inflammatory role for V alpha 14 NK T cells in Mycobacterium bovis bacillus Calmette-Guérin-infected mice.
Dieli F; Taniguchi M; Kronenberg M; Sidobre S; Ivanyi J; Fattorini L; Iona E; Orefici G; De Leo G; Russo D; Caccamo N; Sireci G; Di Sano C; Salerno A
J Immunol; 2003 Aug; 171(4):1961-8. PubMed ID: 12902499
[TBL] [Abstract][Full Text] [Related]
48. Characterization of lung gamma delta T cells following intranasal infection with Mycobacterium bovis bacillus Calmette-Guérin.
Dieli F; Ivanyi J; Marsh P; Williams A; Naylor I; Sireci G; Caccamo N; Di Sano C; Salerno A
J Immunol; 2003 Jan; 170(1):463-9. PubMed ID: 12496432
[TBL] [Abstract][Full Text] [Related]
49. Immunohistochemical detection of pro-inflammatory and anti-inflammatory cytokines in granulomas in cattle with natural Mycobacterium bovis infection.
Canal AM; Pezzone N; Cataldi A; Zumarraga M; Larzabal M; Garbaccio S; Fernandez A; Dominguez L; Aranaz A; Rodriguez-Bertos A
Res Vet Sci; 2017 Feb; 110():34-39. PubMed ID: 28159234
[TBL] [Abstract][Full Text] [Related]
50. Dominant-negative tumor necrosis factor protects from Mycobacterium bovis Bacillus Calmette Guérin (BCG) and endotoxin-induced liver injury without compromising host immunity to BCG and Mycobacterium tuberculosis.
Olleros ML; Vesin D; Lambou AF; Janssens JP; Ryffel B; Rose S; Frémond C; Quesniaux VF; Szymkowski DE; Garcia I
J Infect Dis; 2009 Apr; 199(7):1053-63. PubMed ID: 19222369
[TBL] [Abstract][Full Text] [Related]
51. A protective and agonistic function of IL-12p40 in mycobacterial infection.
Hölscher C; Atkinson RA; Arendse B; Brown N; Myburgh E; Alber G; Brombacher F
J Immunol; 2001 Dec; 167(12):6957-66. PubMed ID: 11739515
[TBL] [Abstract][Full Text] [Related]
52. Immune response to Mycobacterium bovis bacille Calmette Guérin infection in major histocompatibility complex class I- and II-deficient knock-out mice: contribution of CD4 and CD8 T cells to acquired resistance.
Ladel CH; Daugelat S; Kaufmann SH
Eur J Immunol; 1995 Feb; 25(2):377-84. PubMed ID: 7875199
[TBL] [Abstract][Full Text] [Related]
53. Differential Effects of Mycobacterium bovis BCG on Macrophages and Dendritic Cells from Murine Spleen.
Xu Z; Meng C; Qiang B; Gu H; Sun L; Yin Y; Pan Z; Chen X; Jiao X
Int J Mol Sci; 2015 Oct; 16(10):24127-38. PubMed ID: 26473844
[TBL] [Abstract][Full Text] [Related]
54. CD27low CD4 T lymphocytes that accumulate in the mouse lungs during mycobacterial infection differentiate from CD27high precursors in situ, produce IFN-gamma, and protect the host against tuberculosis infection.
Kapina MA; Shepelkova GS; Mischenko VV; Sayles P; Bogacheva P; Winslow G; Apt AS; Lyadova IV
J Immunol; 2007 Jan; 178(2):976-85. PubMed ID: 17202360
[TBL] [Abstract][Full Text] [Related]
55. Contribution of transmembrane tumor necrosis factor to host defense against Mycobacterium bovis bacillus Calmette-guerin and Mycobacterium tuberculosis infections.
Olleros ML; Guler R; Vesin D; Parapanov R; Marchal G; Martinez-Soria E; Corazza N; Pache JC; Mueller C; Garcia I
Am J Pathol; 2005 Apr; 166(4):1109-20. PubMed ID: 15793291
[TBL] [Abstract][Full Text] [Related]
56. Enhanced macrophage activity in granulomatous lesions of immune mice challenged with Mycobacterium tuberculosis.
Ordway D; Harton M; Henao-Tamayo M; Montoya R; Orme IM; Gonzalez-Juarrero M
J Immunol; 2006 Apr; 176(8):4931-9. PubMed ID: 16585589
[TBL] [Abstract][Full Text] [Related]
57. Mycobacterial granulomas: keys to a long-lasting host-pathogen relationship.
Co DO; Hogan LH; Kim SI; Sandor M
Clin Immunol; 2004 Nov; 113(2):130-6. PubMed ID: 15451467
[TBL] [Abstract][Full Text] [Related]
58. Strain differences in mouse cellular responses to Mycobacterium lepraemurium and BCG subcutaneous infections. I. Analysis of cell surface phenotype in local granulomas.
Roch F; Bach MA
Clin Exp Immunol; 1990 Jun; 80(3):332-8. PubMed ID: 2197047
[TBL] [Abstract][Full Text] [Related]
59. Cellular and Cytokine Responses in the Granulomas of Asymptomatic Cattle Naturally Infected with Mycobacterium bovis in Ethiopia.
Tulu B; Martineau HM; Zewude A; Desta F; Jolliffe DA; Abebe M; Balcha TT; Belay M; Martineau AR; Ameni G
Infect Immun; 2020 Nov; 88(12):. PubMed ID: 32958527
[TBL] [Abstract][Full Text] [Related]
60. Bacillus Calmette-Guérin shares with virulent Mycobacterium tuberculosis the capacity to subvert monocyte differentiation into dendritic cell: implication for its efficacy as a vaccine preventing tuberculosis.
Gagliardi MC; Teloni R; Mariotti S; Iona E; Pardini M; Fattorini L; Orefici G; Nisini R
Vaccine; 2004 Sep; 22(29-30):3848-57. PubMed ID: 15364431
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
